Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Armstrong

Showing results (791-800 of 897) with videos related to

Pageof 90
Sort By:
Plos One|January 25, 2023
Inflated expectations: Rare-variant association analysis using public controlsJung Kim, Danielle M Karyadi, Stephen W Hartley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2019
Promoting Breast Cancer Surveillance: The EMPOWER Study, a Randomized Clinical Trial in the Childhood Cancer Survivor StudyKevin C Oeffinger, Jennifer S Ford, Chaya S Moskowitz, et al.
The Lancet. Oncology|April 9, 2011
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomasM J van den Bent, J S Wefel, D Schiff, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Trans-ancestral genetic study of diabetes mellitus risk in survivors of childhood cancer: a report from the St. Jude Lifetime Cohort and the Childhood Cancer Survivor StudyCindy Im, Achal Neupane, Jessica L Baedke, et al.
The Lancet. Oncology|May 31, 2025
Contributions of cancer treatment and genetic predisposition to risk of subsequent neoplasms in long-term survivors of childhood cancer: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor StudyAchal Neupane, Qi Liu, Siddhant Taneja, et al.
Journal of the National Cancer Institute|March 6, 2024
Health-related quality of life and DNA methylation-based aging biomarkers among survivors of childhood cancerNoel-Marie Plonski, Yue Pan, Cheng Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2020
Development and validation of an age-scalable cardiac model with substructures for dosimetry in late-effects studies of childhood cancer survivorsSuman Shrestha, Aashish C Gupta, James E Bates, et al.
JAMA Oncology|June 5, 2025
Body Mass Index, Physical Activity, and Subsequent Neoplasm Risk Among Childhood Cancer SurvivorsLenat Joffe, Sedigheh Mirzaei, Shalini Bhatia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2021
Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor StudyKevin C Oeffinger, Kayla L Stratton, Melissa M Hudson, et al.
Neuro-Oncology|January 14, 2014
Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastomaJames G Gurney, Johnnie K Bass, Arzu Onar-Thomas, et al.
Pageof 90

Showing results (791-800 of 897) with videos related to

Sort By:
Pageof 90
Plos One|January 25, 2023
Inflated expectations: Rare-variant association analysis using public controlsJung Kim, Danielle M Karyadi, Stephen W Hartley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2019
Promoting Breast Cancer Surveillance: The EMPOWER Study, a Randomized Clinical Trial in the Childhood Cancer Survivor StudyKevin C Oeffinger, Jennifer S Ford, Chaya S Moskowitz, et al.
The Lancet. Oncology|April 9, 2011
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomasM J van den Bent, J S Wefel, D Schiff, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Trans-ancestral genetic study of diabetes mellitus risk in survivors of childhood cancer: a report from the St. Jude Lifetime Cohort and the Childhood Cancer Survivor StudyCindy Im, Achal Neupane, Jessica L Baedke, et al.
The Lancet. Oncology|May 31, 2025
Contributions of cancer treatment and genetic predisposition to risk of subsequent neoplasms in long-term survivors of childhood cancer: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor StudyAchal Neupane, Qi Liu, Siddhant Taneja, et al.
Journal of the National Cancer Institute|March 6, 2024
Health-related quality of life and DNA methylation-based aging biomarkers among survivors of childhood cancerNoel-Marie Plonski, Yue Pan, Cheng Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2020
Development and validation of an age-scalable cardiac model with substructures for dosimetry in late-effects studies of childhood cancer survivorsSuman Shrestha, Aashish C Gupta, James E Bates, et al.
JAMA Oncology|June 5, 2025
Body Mass Index, Physical Activity, and Subsequent Neoplasm Risk Among Childhood Cancer SurvivorsLenat Joffe, Sedigheh Mirzaei, Shalini Bhatia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2021
Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor StudyKevin C Oeffinger, Kayla L Stratton, Melissa M Hudson, et al.
Neuro-Oncology|January 14, 2014
Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastomaJames G Gurney, Johnnie K Bass, Arzu Onar-Thomas, et al.
Pageof 90